SABBY MANAGEMENT, LLC Insider Trading $AKTX Akari Therapeutics Plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SABBY MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SABBY MANAGEMENT, LLC. SABBY MANAGEMENT, LLC is 10% Owner in ReShape Lifesciences Inc. ($ETRM) and 10% Owner in Rosetta Genomics Ltd. ($ROSG) and 10% Owner in Akari Therapeutics Plc ($AKTX).
SABBY MANAGEMENT, LLC in Akari Therapeutics Plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SABBY MANAGEMENT, LLC: 10% Owner
Holdings: 778,030 shares
Current Value: $5,446,210
Latest Transaction: Apr 17 2014
$AKTX Market Capitalization: $82.90M
$AKTX Previous Close: $7.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SABBY MANAGEMENT, LLC in Akari Therapeutics Plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKTX, RSLS, ROSG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.00 | 17,100 | 85,500 | 778,030 | 760.9 K to 778 K (+2.25 %) |
| Apr 17 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.21 | 3,000 | 15,630 | 760,930 | 757.9 K to 760.9 K (+0.40 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.15 | 100 | 515 | 757,930 | 757.8 K to 757.9 K (+0.01 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.25 | 1,400 | 7,350 | 757,830 | 756.4 K to 757.8 K (+0.19 %) |
| Apr 11 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.51 | 1,075 | 5,923 | 756,430 | 755.4 K to 756.4 K (+0.14 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.36 | 35,500 | 190,280 | 755,355 | 719.9 K to 755.4 K (+4.93 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.00 | 3,754 | 22,524 | 719,855 | 716.1 K to 719.9 K (+0.52 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 5.64 | 16,900 | 95,316 | 716,101 | 699.2 K to 716.1 K (+2.42 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.08 | 11,250 | 68,400 | 699,201 | 688 K to 699.2 K (+1.64 %) |
| Apr 08 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.00 | 1,000 | 6,000 | 687,951 | 687 K to 688 K (+0.15 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.15 | 2,500 | 15,375 | 686,951 | 684.5 K to 687 K (+0.37 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.12 | 7,496 | 45,876 | 684,451 | 677 K to 684.5 K (+1.11 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.08 | 7,375 | 44,840 | 676,955 | 669.6 K to 677 K (+1.10 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.18 | 500 | 3,090 | 669,580 | 669.1 K to 669.6 K (+0.07 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.65 | 2,400 | 15,960 | 661,144 | 658.7 K to 661.1 K (+0.36 %) |
| Apr 02 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.35 | 7,936 | 50,394 | 669,080 | 661.1 K to 669.1 K (+1.20 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.61 | 1,700 | 11,237 | 658,744 | 657 K to 658.7 K (+0.26 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.65 | 13,300 | 88,445 | 657,044 | 643.7 K to 657 K (+2.07 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.86 | 900 | 6,174 | 643,744 | 642.8 K to 643.7 K (+0.14 %) |
| Mar 27 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.90 | 303 | 2,091 | 642,844 | 642.5 K to 642.8 K (+0.05 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.71 | 2,400 | 16,104 | 642,541 | 640.1 K to 642.5 K (+0.37 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.83 | 4,900 | 33,467 | 640,141 | 635.2 K to 640.1 K (+0.77 %) |
| Mar 24 2014 | AKTX | Akari Therapeutics ... | SABBY MANAGEMENT, LLC | 10% Owner | Buy | P | 6.90 | 3,800 | 26,220 | 635,241 | 631.4 K to 635.2 K (+0.60 %) |
Page: 1